Biomea Fusion’s early-stage investigational diabetes treatment BMF-291 has been slapped with a full FDA clinical hold on its ...

After rejecting a previous takeover offer from Future Pak, Vanda Pharmaceuticals is now fielding another acquisition proposal ...

AbbVie’s antibody-drug conjugate Elahere, developed by ImmunoGen, elicited a nearly 52% objective response rate in heavily ...

Both Eli Lilly and the partnered companies Boehringer Ingelheim and Zealand Pharma have mid-stage data readouts this week, ...

BMS presented late-stage results on Tuesday at the ASCO annual meeting which showed the combination of Opdivo and Yervoy ...

In a briefing document ahead of Monday’s FDA advisory committee meeting, the agency’s internal reviewers have raised several ...

Boehringer Ingelheim and Zealand Pharma on Friday unveiled Phase II findings for their investigational GLP-1/glucagon ...

Structure Therapeutics is offering over nine million shares on the heels of mid-stage data for its oral GLP-1 receptor ...

How do we ensure strategic vision and thoughtful implementation when pursuing new opportunities in science and technology?

Securing top talent in research and development and manufacturing will remain challenging for life sciences companies in 2024 ...

If you overidentify with your job, there are ways to find self-worth outside of work, starting with using your transferable ...

Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you.